Abstract

AbstractThe primary goal of this paper was to uncover the drivers of digital transformation (DT) in the pharmaceutical industry. The Covid-19 pandemic and tightening regulatory standards in the global pharma industry necessitated pharma executives need to understand the most critical drivers of digitalizing the sector and charting a new path that improves production processes and streamlines these companies’ overall supply chain. This research aims to identify the drivers for DT in the pharmaceutical industry. The Web of Science Core Collection and Scopus gathered relevant data for the research study. The research employs objective analysis to ensure that more reliable conclusions were drawn following the study. The study also proposed that external and internal factors, such as supply chain difficulties and data silos, impact DT adoption in the pharmaceutical sector.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call